ENDRA Life Sciences Inc. (NDRA) vs Inotiv, Inc. (NOTVQ)

ENDRA Life Sciences Inc. and Inotiv, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $8.9M against $2.8M — 3.2× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −17.1%) and the lower return on invested capital (−539.9% vs −6.19%). Across the 16 metrics below, ENDRA Life Sciences Inc. leads on 9 and Inotiv, Inc. on 7.

Valuation

Metric NDRA NOTVQ Diagnostics & Research median
P/E n/m n/m 33.95
P/S 22.35 0.00 4.87
P/B 1.27 0.00 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m 60.99 25.20
EV/Sales 7.61 1.57 5.66
Earnings yield (104.64%) (25,300.00%) (1.75%)
Free cash flow yield (98.06%) (2,858.05%) (0.13%)

Profitability

Metric NDRA NOTVQ Diagnostics & Research median
Gross margin 0.00% 22.94% 50.89%
Operating margin 0.00% (9.48%) (8.57%)
Net margin 0.00% (17.14%) (6.37%)
Free cash flow margin 0.00% (1.95%) 0.00%
Return on equity (152.04%) (74.09%) (2.92%)
Return on assets (110.08%) (11.85%) (6.71%)
Return on invested capital (539.89%) (6.19%) 0.00%

Growth

Metric NDRA NOTVQ Diagnostics & Research median
Revenue growth (TTM) — 5.61% 7.69%
EPS growth (last fiscal year) 84.32% 49.64% —
Revenue growth, 5-year CAGR — 53.36% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 7.10 0.27 2.02
Net debt to EBITDA 0.14 12.68 0.78

Dividend

Metric NDRA NOTVQ Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric NDRA NOTVQ Diagnostics & Research median
Market cap 8.89m 2.79m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack